CD44 and cancer: KEGG pathway enrichment revealed upregulation of focal adhesion and proteoglycans in cancer pathways—the latter featuring CD44 as a key molecule involved in MASLD-associated metastases (Data S3 and Supplementary Fig. 3k, l).